Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'NITROGEN MUSTARD' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 241 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Janss, AJ; Maity, A; Tang, CB; Muschel, RJ; McKenna, WG; Sutton, L; Phillips, PC
      Decreased cyclin B1 expression contributes to G(2) delay in human brain tumor cells after treatment with camptothecin

      NEURO-ONCOLOGY
    2. Panasci, L; Paiement, JP; Christodouplopoulos, G; Belenkov, A; Malapetsa, A; Aloyz, R
      Chlorambucil drug resistance in chronic lymphocytic leukemia: The emergingrole of DNA repair

      CLINICAL CANCER RESEARCH
    3. Kuang, J; He, GG; Huang, ZF; Khokhar, AR; Siddik, ZH
      Bimodal effects of 1R,2R-diaminocyclohexane(trans-diacetato)(dichloro)platinum(IV) on cell cycle checkpoints

      CLINICAL CANCER RESEARCH
    4. Kim-James, HY; Heffernan, MP
      The diagnosis, evaluation, and treatment of cutaneous T-cell lymphoma

      CURRENT PROBLEMS IN DERMATOLOGY-US
    5. Kao, GD; McKenna, WG; Yen, TJ
      Detection of repair activity during the DNA damage-induced G2 delay in human cancer cells

      ONCOGENE
    6. Denny, WA
      DNA minor groove alkylating agents

      CURRENT MEDICINAL CHEMISTRY
    7. Behnam-Motlagh, P; Sandstrom, PE; Henriksson, R; Grankvist, K
      Diverging effects of 5-HT3 receptor antagonists ondansetron and granisetron on estramustine-inhibited cellular potassium transport

      PHARMACOLOGY & TOXICOLOGY
    8. Ghielmini, M; Van der Bosch, S; Bosshard, M; Pampallona, S; Gabutti, L; Egger, HP; Kiess, M; Cavalli, F; Sessa, C
      Phase I-II study of escalating doses of amifostine combined with high-dosecyclophosphamide

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    9. Kadar, T; Turetz, J; Fishbine, E; Sahar, R; Chapman, S; Amir, A
      Characterization of acute and delayed ocular lesions induced by sulfur mustard in rabbits

      CURRENT EYE RESEARCH
    10. Sipos, EP; Witham, TF; Ratan, R; Burger, PC; Baraban, J; Li, KW; Piantadosi, S; Brem, H
      L-buthionine sulfoximine potentiates the antitumor effect of 4-hydroperoxycyclophosphamide when administered locally in a rat glioma model

      NEUROSURGERY
    11. Bito, LZ
      A new approach to the medical management of glaucoma, from the bench to the clinic, and beyond - The Proctor lecture

      INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
    12. Elder, RT; Yu, M; Chen, MZ; Zhu, XD; Yanagida, M; Zhao, YQ
      HIV-1 Vpr induces cell cycle G2 arrest in fission yeast (Schizosaccharomyces pombe) through a pathway involving regulatory and catalytic subunits of PP2A and acting on both Wee1 and Cdc25

      VIROLOGY
    13. Vinson, RK; Hales, BF
      Expression of base excision, mismatch, and recombination repair genes in the organogenesis-stage rat conceptus and effects of exposure to a genotoxicteratogen, 4-hydroperoxycyclophosphamide

      TERATOLOGY
    14. Gaynor, EM; Chen, ISY
      Analysis of apoptosis induced by HIV-1 Vpr and examination of the possiblerole of the hHR23A protein

      EXPERIMENTAL CELL RESEARCH
    15. Minemoto, Y; Gannon, J; Masutani, M; Nakagama, H; Sasagawa, T; Inoue, M; Masamune, Y; Yamashita, K
      Characterization of adriamycin-induced G2 arrest and its abrogation by caffeine in FL-amnion cells with or without p53

      EXPERIMENTAL CELL RESEARCH
    16. Stone, ML; Styles, AR; Cockerell, CJ; Pandya, AG
      Hypopigmented mycosis fungoides: A report of 7 cases and review of the literature

      CUTIS
    17. Noll, DM; Noronha, AM; Miller, PS
      Synthesis and characterization of DNA duplexes containing an (NC)-C-4-ethyl-(NC)-C-4 interstrand cross-link

      JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
    18. Ferguson, LR; Turner, PM; Denny, WA
      The mutagenic spectrum of acridine-linked aniline nitrogen mustards in AS52 cells: implications of DNA targeting with high selectivity for adenine orguanine bases

      MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS
    19. Baraldi, PG; Spalluto, G; Cacciari, B; Romagnoli, R
      DNA minor groove alkylating agents structurally related to distamycin A

      EXPERT OPINION ON THERAPEUTIC PATENTS
    20. Rappeneau, S; Baeza-Squiban, A; Marano, F; Calvet, JH
      Efficient protection of human bronchial epithelial cells against sulfur and nitrogen mustard cytotoxicity using drug combinations

      TOXICOLOGICAL SCIENCES
    21. Snell, J; Lillquist, DR; Lewis-Younger, C; Wallace, DO
      Exposure at home to airborne concentrations of nitrogen mustard during topical application for the treatment of mycosis fungoides: A case study

      DERMATOLOGY
    22. Chen, H; Lu, XY; Gao, RY; Zhou, J; Wang, QS
      Separation of chiral phosphorus compounds on the substituted beta-cyclodextrin stationary phase in normal-phase liquid chromatography

      CHINESE JOURNAL OF CHEMISTRY
    23. Cozzi, P; Beria, I; Caldarelli, M; Capolongo, L; Geroni, C; Mazzini, S; Ragg, E
      Phenyl sulfur mustard derivatives of distamycin A

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    24. Cozzi, P; Beria, I; Caldarelli, M; Geroni, C; Mongelli, N; Pennella, G
      Cytotoxic alpha-bromoacrylic derivatives of distamycin analogues modified at the amidino moiety

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    25. Capizzi, RL; Oster, W
      Chemoprotective and radioprotective effects of amifostine: An update of clinical trials

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    26. Struck, RF; Davis, RL; Berardini, MD; Loechler, EL
      DNA guanine-guanine crosslinking sequence specificity of isophosphoramide mustard, the alkylating metabolite of the clinical antitumor agent ifosfamide

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    27. Chauncey, TR; Gooley, TA; Lloid, ME; Schubert, MM; Lilleby, K; Holmberg, L; Bensinger, WI
      Pilot trial of cytoprotection with amifostine given with high-dose chemotherapy and autologous peripheral blood stem cell transplantation

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    28. Dronkert, MLG; de Wit, J; Boeve, M; Vasconcelos, ML; van Steeg, H; Tan, TLR; Hoeijmakers, JHJ; Kanaar, R
      Disruption of mouse SNM1 causes increased sensitivity to the DNA interstrand cross-linking agent mitomycin C

      MOLECULAR AND CELLULAR BIOLOGY
    29. Pu, QQ; Bianchi, P; Bezwoda, WR
      Alkylator resistance in human B lymphoid cell lines: (1) melphalan accumulation, cytotoxicity, interstrand-DNA-crosslinks, cell cycle analysis, and glutathione content in the melphalan-sensitive B-lymphocytic cell line(WIL2)and in the melphalan-resistant B-CLL cell line(WSU-CLL)

      ANTICANCER RESEARCH
    30. Pu, QQ; Bezwoda, WR
      Alkylator resistance in human B lymphoid cell lines: (2) increased levels of topoisomerase II expression and function in a melphalan-resistant B-CLL cell line

      ANTICANCER RESEARCH
    31. Castiglione, F; Porcile, G; Gridelli, C
      The potential role of amifostine in the treatment of non small cell lung cancer

      LUNG CANCER
    32. Elder, RT; Yu, M; Chen, MZ; Edelson, S; Zhao, YQ
      Cell cycle G2 arrest induced by HIV-1 Vpr in fission yeast (Schizosaccharomyces pombe) is independent of cell death and early genes in the DNA damagecheckpoint

      VIRUS RESEARCH
    33. He, T; Wei, D; Fabris, D; Fenselau, C
      Intracellular sequestration of anti-tumor drugs by metallothionein

      CELLULAR AND MOLECULAR BIOLOGY
    34. Wilson, DW; Lame, MW; Dunston, SK; Segall, HJ
      DNA damage cell checkpoint activities are altered in monocrotaline pyrrole-induced cell cycle arrest in human pulmonary artery endothelial cells

      TOXICOLOGY AND APPLIED PHARMACOLOGY
    35. Senyigit, A; Bayram, H; Babayigit, C; Topcu, F; Balci, AE; Satici, O
      Comparison of the effectiveness of some pleural sclerosing agents used forcontrol of effusions in malignant pleural mesothelioma: A review of 117 cases

      RESPIRATION
    36. Cozzi, P
      Recent outcome in the field of distamycin-derived minor groove binders

      FARMACO
    37. Chen, S; Huang, ZH; Huang, JL
      Synthesis and characterization of novel kinds of polyethylene oxide drugs containing 5-fluorouracil and nitrogen mustard at one end and 4-amino-N-(2-pyrimidinyl) benzene sulfonamide at the other end

      EUROPEAN POLYMER JOURNAL
    38. Ferguson, LR; Liu, AP; Denny, WA; Cullinane, C; Talarico, T; Phillips, DR
      Transcriptional blockages in a cell-free system by sequence-selective DNA alkylating agents

      CHEMICO-BIOLOGICAL INTERACTIONS
    39. Capelli, D; Santini, G; De Souza, C; Poloni, A; Marino, G; Montanari, M; Lucesole, M; Brunori, R; Massidda, D; Offidani, M; Leoni, P; Olivieri, A
      Amifostine can reduce mucosal damage after high-dose melphalan conditioning for peripheral blood progenitor cell autotransplant: a retrospective study

      BRITISH JOURNAL OF HAEMATOLOGY
    40. Holl, V; Coelho, D; Silbernagel, L; Keyser, JF; Waltzinger, C; Dufour, P; Bischoff, PL
      Prevention of nitrogen mustard-induced apoptosis in normal and transformedlymphocytes by ebselen

      BIOCHEMICAL PHARMACOLOGY
    41. Hoeger, PH; Nanduri, VR; Harper, JI; Atherton, DA; Pritchard, J
      Long term follow up of topical mustine treatment for cutaneous Langerhans cell histiocytosis

      ARCHIVES OF DISEASE IN CHILDHOOD
    42. Schoenfeld, HA; Witz, G
      DNA-protein cross-link levels in bone marrow cells of mice treated with benzene or trans,trans-muconaldehyde

      JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A
    43. Melton, R; Connors, T; Knox, RJ
      The use of prodrugs in targeted anticancer therapies

      STP PHARMA SCIENCES
    44. Cerutti, ML; D'Orio, E; Davel, L; Colombo, L; Parma, P; Diament, M; Stillitani, I; Gelpi, ME; Leicach, SR; Eijan, AM
      A synthetic, nitrogenated antimetastatic and anti-angiogenic compound withlow toxicity in vivo

      INTERNATIONAL JOURNAL OF ONCOLOGY
    45. Martens, ACM; Hagenbeek, A
      Amifostine (WR2721) for dose escalation in marrow-ablative treatment of leukaemia

      EUROPEAN JOURNAL OF CANCER
    46. Behnam-Motlagh, P; Engstrom, KG; Henriksson, R; Grankvist, K
      Serotoninergic modulation of cell volume response to estramustine: an image-analysis study on perifused individual glioma cells

      EUROPEAN JOURNAL OF CANCER
    47. Sert, V; Cans, C; Tasca, C; Bret-Bennis, L; Oswald, E; Ducommun, B; De Rycke, J
      The bacterial cytolethal distending toxin (CDT) triggers a G2 cell cycle checkpoint in mammalian cells without preliminary induction of DNA strand breaks

      ONCOGENE
    48. Barth, F; Rinaldi-Carmona, M
      The development of cannabinoid antagonists

      CURRENT MEDICINAL CHEMISTRY
    49. Capizzi, RL
      Clinical status and optimal use of amifostine

      ONCOLOGY-NEW YORK
    50. Chinn, DM; Chow, S; Kim, YH; Hoppe, RT
      Total skin electron beam therapy with or without adjuvant topical nitrogenmustard or nitrogen mustard alone as initial treatment of T2 and T3 mycosis fungoides

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    51. Friedman, HS; Pegg, AE; Johnson, SP; Loktionova, NA; Dolan, ME; Modrich, P; Moschel, RC; Struck, R; Brent, TP; Ludeman, S; Bullock, N; Kilborn, C; Keir, S; Dong, Q; Bigner, DD; Colvin, OM
      Modulation of cyclophosphamide activity by O-6-alkylguanine-DNA alkyltransferase

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    52. Brandes, AA; Palmisano, V; Monfardini, S
      Medulloblastoma in adults: clinical characteristics and treatment

      CANCER TREATMENT REVIEWS
    53. Poloni, A; Leoni, P; Curzi, L; Cantori, I; Mancini, S; Montanari, M; Masia, MC; Olivieri, A
      Ex vivo pharmacological purging of leukapheresis collections with nitrogenmustard: Amifostine pretreatment improves both early and late peripheral blood progenitor cell recovery

      EXPERIMENTAL HEMATOLOGY
    54. Baraldi, PG; Balboni, G; Romagnoli, R; Spalluto, G; Cozzi, P; Geroni, C; Mongelli, N; Rutigliano, C; Bianchi, N; Gambari, R
      PNU 157977: a new potent antitumour agent exhibiting low in vivo toxicity in mice injected with L1210 leukaemia cells

      ANTI-CANCER DRUG DESIGN
    55. Kwon, CH
      Metabolism-based anticancer drug design

      ARCHIVES OF PHARMACAL RESEARCH
    56. Baatout, S; Jacquet, P; Jung, T; Hain, J; Michaux, A; Buset, J; Vandecasteele, C; De Saint-Georges, L
      Histone H1 kinase activity in one-cell mouse embryos blocked in the G2 phase by X-irradiation

      ANTICANCER RESEARCH
    57. Capizzi, RL
      The preclinical basis for broad-spectrum selective cytoprotection of normal tissues from cytotoxic therapies by amifostine

      SEMINARS IN ONCOLOGY
    58. Munro, NB; Talmage, SS; Griffin, GD; Waters, LC; Watson, AP; King, JF; Hauschild, V
      The sources, fate, and toxicity of chemical warfare agent degradation products

      ENVIRONMENTAL HEALTH PERSPECTIVES
    59. Arah, IH; Dixon, SC; Horti, J; Figg, WD
      Enhanced activity of estramustine, vinblastine, etoposide, and suramin in prostate carcinoma

      NEOPLASMA
    60. Pu, QQ; Bezwoda, WR
      Induction of alkylator (melphalan) resistance in HL60 cells is accompaniedby increased levels of topoisomerase II expression and function

      MOLECULAR PHARMACOLOGY
    61. Gauthier, B; Trachtman, H
      Pharmacological treatment of nephrotic syndrome

      DRUGS OF TODAY
    62. Jowett, JB; Xie, YM; Chen, ISY
      The presence of human immunodeficiency virus type 1 Vpr correlates with a decrease in the frequency of mutations in a plasmid shuttle vector

      JOURNAL OF VIROLOGY
    63. Berardini, M; Foster, PL; Loechler, EL
      DNA polymerase II (polB) is involved in a new DNA repair pathway for DNA interstrand cross-links in Escherichia coli

      JOURNAL OF BACTERIOLOGY
    64. Hall, AG
      The role of glutathione in the regulation of apoptosis

      EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
    65. Chen, XM; Gray, PJ; Cullinane, C; Phillips, DR
      Differential sensitivity of transcription factors to mustard-damaged DNA

      CHEMICO-BIOLOGICAL INTERACTIONS
    66. Inga, A; Chen, FX; Monti, P; Aprile, A; Campomenosi, P; Menichini, P; Ottaggio, L; Viaggi, S; Abbondandolo, A; Gold, B; Fronza, G
      N-(2-chloroethyl)-N-nitrosourea tethered to lexitropsin induces minor groove lesions at the p53 cDNA that are more cytotoxic than mutagenic

      CANCER RESEARCH
    67. Esteve, E; Bagot, M; Joly, P; Souteyrand, P; Beylot-Barry, M; Vaillant, L; Delaunay, M; Avril, MF; Laroche, L; Grange, F; Thomine, E; Wechsler, J
      A prospective study of cutaneous intolerance to topical mechlorethamine therapy in patients with cutaneous T-cell lymphomas

      ARCHIVES OF DERMATOLOGY
    68. Fan, YH; Gold, B
      Sequence-specificity for DNA interstrand cross-linking by alpha,omega-alkanediol dimethylsulfonate esters: Evidence for DNA distortion by the initialmonofunctional lesion

      JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
    69. SPERRY ML; SKANCHY D; MARINO MT
      HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OF HYDROXYETHYL)-N-(2-(7-GUANINYL)ETHYL)]METHYLAMINE, A REACTION-PRODUCT BETWEEN NITROGEN-MUSTARD AND DNA AND ITS APPLICATION TO BIOLOGICAL SAMPLES

      Journal of chromatography B. Biomedical sciences and applications
    70. YAGHI BM; TURNER PM; DENNY WA; TURNER PR; OCONNOR CJ; FERGUSON LR
      COMPARATIVE MUTATIONAL SPECTRA OF THE NITROGEN-MUSTARD CHLORAMBUCIL AND ITS HALF-MUSTARD ANALOG IN CHINESE-HAMSTER AS52 CELLS

      Mutation research. Fundamental and molecular mechanisms of mutagenesis
    71. MIGLIORE L; COCCHI L; SCARPATO R; SBRANA I
      INDUCTION OF ANEUPLOIDY BY THE ANTINEOPLASTIC DRUG ESTRAMUSTINE IN HUMAN-LYMPHOCYTES

      Mutation research. Genetic toxicology and environmental mutagenesis
    72. Voehringer, DW; Meyn, RE
      Reversing drug resistance in bcl-2-expressing tumor cells by depleting glutathione

      DRUG RESISTANCE UPDATES
    73. WEISS GR; POGGESI I; ROCCHETTI M; DEMARIA D; MOONEYHAM T; REILLY D; VITEK LV; WHALEY F; PATRICIA E; VONHOFF DD; ODWYER P
      A PHASE-I AND PHARMACOKINETIC STUDY OF TALLIMUSTINE [PNU152241 (FCE-24517)] IN PATIENTS WITH ADVANCED CANCER

      Clinical cancer research
    74. WEISS GR; POGGESI I; ROCCHETTI M; DEMARIA D; MOONEYHAM T; REILLY D; VITEK LV; WHALEY F; PATRICIA E; VONHOFF DD; ODWYER P
      A PHASE-I AND PHARMACOKINETIC STUDY OF TALLIMUSTINE [PNU152241 (FCE-24517)] IN PATIENTS WITH ADVANCED CANCER

      Clinical cancer research
    75. KHAN MA; TRAVIS LB; LYNCH CF; SOINI Y; HRUSZKEWYCZ AM; DELGADO RM; HOLOWATY EJ; VANLEEUWEN FE; GLIMELIUS B; STOVALL M; BOICE JD; TARONE RE; BENNETT WP
      P53 MUTATIONS IN CYCLOPHOSPHAMIDE-ASSOCIATED BLADDER-CANCER

      Cancer epidemiology, biomarkers & prevention
    76. THOMAS HC; LAME MW; MORIN D; WILSON DW; SEGALL HJ
      PROLONGED CELL-CYCLE ARREST ASSOCIATED WITH ALTERED CDC2 KINASE IN MONOCROTALINE PYRROLE-TREATED PULMONARY-ARTERY ENDOTHELIAL-CELLS

      American journal of respiratory cell and molecular biology
    77. Chen, ZL; Chen, JR; Wan, WQ; Xu, DY
      Synthesis of porphyrin nitrogen mustards with potential anti-tumor activities in chemotherapy and photodynamic therapy

      CHINESE JOURNAL OF CHEMISTRY
    78. KOHN KW
      FUNCTIONAL CAPABILITIES OF MOLECULAR NETWORK COMPONENTS CONTROLLING THE MAMMALIAN G1 S CELL-CYCLE PHASE-TRANSITION/

      Oncogene
    79. LOIRAT C; BAUDOUIN V; CLOAREC S; PEUCHMAUR M
      TREATMENT OF NEPHROTIC SYNDROME IN CHILDR EN

      Archives de pediatrie
    80. AMICHAI B; GRUNWALD MH; GOLDSTEIN J; FINKELSTEIN E; HALEVY S
      SMALL MALIGNANT-MELANOMA IN PATIENTS WITH MYCOSIS-FUNGOIDES

      JEADV. Journal of the European Academy of Dermatology and Venereology
    81. MUNN S; CHU AC
      LANGERHANS CELL HISTIOCYTOSIS OF THE SKIN

      Hematology/oncology clinics of North America
    82. ARCECI RJ; BRENNER MK; PRITCHARD J
      CONTROVERSIES AND NEW APPROACHES TO TREATMENT OF LANGERHANS CELL HISTIOCYTOSIS

      Hematology/oncology clinics of North America
    83. TIMMERBOSSCHA H; DEVRIES EGE; MEIJER C; OOSTERHUIS JW; MULDER NH
      DIFFERENTIAL-EFFECTS OF ALL-TRANS-RETINOIC ACID, DOCOSAHEXAENOIC ACID, AND HEXADECYLPHOSPHOCHOLINE ON CISPLATIN-INDUCED CYTOTOXICITY AND APOPTOSIS IN A CISPLANTIN-SENSITIVE AND RESISTANT HUMAN EMBRYONAL CARCINOMA CELL

      Cancer chemotherapy and pharmacology
    84. BERGENHEIM AT; HENRIKSSON R
      PHARMACOKINETICS AND PHARMACODYNAMICS OF ESTRAMUSTINE PHOSPHATE

      Clinical pharmacokinetics
    85. RODRIGUEZ M; MANTOLANSARMIENTO B; GONZALEZHERNANDEZ T
      EFFECTS OF ETHYLCHOLINE MUSTARD AZIRINIUM ION (AF64A) ON THE CHOLINE-ACETYLTRANSFERASE AND NITRIC-OXIDE SYNTHASE ACTIVITIES IN MESOPONTINE CHOLINERGIC NEURONS OF THE RAT

      Neuroscience
    86. NYLEN U; HE QM; WELANDER I; LEWIN F; SKOG S
      CISPLATIN-INDUCED INHIBITION OF P34(CDC2) IS ABOLISHED BY 5-FLUOROURACIL

      Acta oncologica
    87. FRANCHITTO A; PICHIERRI P; MOSESSO P; PALITTI F
      CAFFEINE EFFECT ON THE MITOTIC DELAY INDUCED BY G2 TREATMENT WITH UVCOR MITOMYCIN-C

      Mutagenesis
    88. SMAILL JB; FAN JY; PAPA PV; OCONNOR CJ; DENNY WA
      MONOFUNCTIONAL AND DIFUNCTIONAL NITROGEN-MUSTARD ANALOGS OF THE DNA MINOR-GROOVE BINDER PIBENZIMOL - SYNTHESIS, CYTOTOXICITY AND INTERACTION WITH DNA

      Anti-cancer drug design
    89. OLAJOS EJ; OLSON CT; SALEM H; SINGER AW; HAYES TL; MENTON RG; MILLER TL; ROSSO T; MACIVER B
      EVALUATION OF NEUTRALIZED CHEMICAL-AGENT IDENTIFICATION SETS (CAIS) FOR SKIN INJURY WITH AN OVERVIEW OF THE VESICANT POTENTIAL OF AGENT DEGRADATION PRODUCTS

      Journal of applied toxicology
    90. OLAJOS EJ; MORGAN EW; RENNE RA; SALEM H; MCVEETY B; JOHNSON R; PHELPS RL
      ACUTE INHALATION TOXICITY OF NEUTRALIZED CHEMICAL-AGENT IDENTIFICATION SETS (CAIS) CONTAINING AGENT IN CHLOROFORM

      Journal of applied toxicology
    91. Morand, JJ; Colineau, X; Carsuzaa, F; Lescout, JM; Carloz, E; Jacquet, P; Benderitter, T
      Ulcerative vulvitis, gingivitis and cranial tumor

      REVUE DE MEDECINE INTERNE
    92. SMITH KJ; SMITH WJ; HAMILTON T; SKELTON HG; GRAHAM JS; OKERBERG C; MOELLER R; HACKLEY BE
      HISTOPATHOLOGIC AND IMMUNOHISTOCHEMICAL FEATURES IN HUMAN SKIN AFTER EXPOSURE TO NITROGEN AND SULFUR MUSTARD

      The American journal of dermatopathology
    93. LATZ D; SCHULZE T; MANEGOLD C; SCHRAUB P; FLENTJE M; WEBER KJ
      COMBINED EFFECTS OF IONIZING-RADIATION AND 4-HYDROPEROXYIFOSFAMIDE IN-VITRO

      Radiotherapy and oncology
    94. MOORTHY RS; VALLURI S; JAMPOL LM
      DRUG-INDUCED UVEITIS

      Survey of ophthalmology
    95. LIDSTROM P; BONASERA TA; MARQUEZM M; NILSSON S; BERGSTROM M; LANGSTROM B
      SYNTHESIS AND IN-VITRO EVALUATION OF [CARBONYL-C-11]ESTRAMUSTINE AND [CARBONYL-C-11]ESTRAMUSTINE PHOSPHATE

      Steroids
    96. WILSON WR; FERRY DM; TERCEL M; ANDERSON RF; DENNY WA
      REDUCTION OF NITROARYLMETHYL QUATERNARY AMMONIUM PRODRUGS OF MECHLORETHAMINE BY RADIATION

      Radiation research
    97. JONES GB; CHAPMAN BJ; MATHEWS JE
      MIXED-LIGAND ARENECHROMIUM CARBONYL-COMPLEXES AS ELECTRONIC MODULATORS

      Journal of organic chemistry
    98. ATWELL GJ; FAN JY; TAN K; DENNY WA
      DNA-DIRECTED ALKYLATING-AGENTS - 7 - SYNTHESIS, DNA INTERACTION, AND ANTITUMOR-ACTIVITY OF BIS(HYDROXYMETHYL)-SUBSTITUTED AND BIS(CARBAMATE)-SUBSTITUTED PYRROLIZINES AND IMIDAZOLES

      Journal of medicinal chemistry
    99. GERLACH B; STEIN A; FISCHER R; WOZEL G; DITTERT DD; RICHTER G
      LANGERHANS-CELL HISTIOCYTOSIS IN ELDERLY PATIENTS

      Hautarzt
    100. BARRATT RA; KAO G; MCKENNA WG; KUANG J; MUSCHEL RJ
      THE G(2) BLOCK INDUCED BY DNA-DAMAGE - A CAFFEINE-RESISTANT COMPONENTINDEPENDENT OF CDC25C, MPM-2 PHOSPHORYLATION, AND H1 KINASE-ACTIVITY

      Cancer research


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 26/01/21 alle ore 06:13:05